Key result
Smoking cessation in T2D is linked to ~10% lower heart failure risk vs continued smoking.
Why the study?
Heart failure is a common initial cardiovascular manifestation in type 2 diabetes, but data on HF incidence according to changes in smoking behaviors are lacking.
Does smoking cessation or reduction reduce the risk of incident heart failure in current smokers with type 2 diabetes?
Cohort (n=365,352)
Yes
Does smoking cessation or reduction reduce the risk of incident heart failure in current smokers with type 2 diabetes?
Effect estimate: aHR 0.90 (95% CI 0.86-0.95)
Smoking cessation, but not reduction, is associated with a lower risk of incident heart failure in patients with type 2 diabetes who smoke.
Smoking cessation may lower HF risk in type 2 diabetes; hypothesis-generating, needs randomized confirmation before practice change.
BACKGROUND Heart failure (HF) is one of the most common initial manifestations of cardiovascular disease in patients with type 2 diabetes. Although smoking is an independent risk factor for HF, there is a lack of data for the incidence of HF according to changes in smoking behaviors in patients with type 2 diabetes. OBJECTIVE We aimed to examine the association between interval changes in smoking behavior and the risk of HF among patients with type 2 diabetes. METHODS We conducted a retrospective cohort study using the National Health Insurance Service database. We identified 365,352 current smokers with type 2 diabetes who had 2 consecutive health screenings (2009-2012) and followed them until December 31, 2018, for the incident HF. Based on smoking behavior changes between 2 consecutive health screenings, participants were categorized into quitter, reducer I (≥50% reduction) and II (<50% reduction), sustainer (reference group), and increaser groups. RESULTS During a median follow-up of 5.1 (IQR 4.0-6.1) years, there were 13,879 HF cases (7.8 per 1000 person-years). Compared to sustainers, smoking cessation was associated with lower risks of HF (adjusted hazard ratio [aHR] 0.90, 95% CI0.86-0.95), whereas increasers showed higher risks of HF than sustainers; heavy smokers who increased their level of smoking had a higher risk of HF (aHR 1.13, 95% CI 1.04-1.24). In the case of reducers, the risk of HF was not reduced but rather increased slightly (reducer I: aHR 1.14, 95% CI 1.08-1.21; reducer II: aHR 1.03, 95% CI 0.98-1.09). Consistent results were noted for subgroup analyses including type 2 diabetes severity, age, and sex. CONCLUSIONS Smoking cessation was associated with a lower risk of HF among patients with type 2 diabetes, while increasing smoking amount was associated with a higher risk for HF than in those sustaining their smoking amount. There was no benefit from reduction in smoking amount.
No takes yet. Share an insight, caveat, or question.
Yoo et al. (2023) conducted a cohort in Type 2 diabetes (n=365,352). Smoking behavior changes (cessation, reduction, increase) vs. Sustaining smoking amount was evaluated on Incident heart failure (aHR 0.90, 95% CI 0.86-0.95). Smoking cessation in patients with type 2 diabetes was associated with a lower risk of heart failure compared to sustaining smoking (aHR 0.90; 95% CI 0.86-0.95).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: